CNN: Moderna applies for FDA authorization of its COVID-19 vaccine
First patient enrolled in UC/UC Health Moderna vaccine trial tells his story
Jarelle Marshall, the first patient administered a dose in the UC/UC Health Moderna COVID-19 vaccine trial was interviewed by CNN about his experience. Marshall received the first dose on August 25, 2020 with a follow up dose about four weeks later.
Jarelle Marshall receives the first dose of the UC/UC Health Moderna COVID-19 vaccine trial. Photo/Colleen Kelley/UC Creative + Brand
When asked by CNN host Don Lemon about what getting a dose was like, Marshall said, "Other than a sore arm I didn't have any really negative side effects. After the second injection, the day after, my temperature rose a couple degrees around 99 for about a day which made me a little nervous. I was checking my temperature every hour or two. But after that, you know, I was fine. I didn't get sick or didn't have any problems."
Marshall also said that one of the reasons he volunteered for the trial was to set an example for his son.
"I always tell my son, what really matters is what you do when people aren't looking."
Watch the entire segment here and read more about the UC/UC Health Moderna vaccine trial here.
Lead photo Colleen Kelley/UC Creative + Brand
Next Lives Here
The University of Cincinnati is classified as a Research 1 institution by the Carnegie Commission and is ranked in the National Science Foundation's Top-35 public research universities. UC's medical, graduate and undergraduate students and faculty investigate problems and innovate solutions with real-world impact. Next Lives Here.
Related Stories
Pocket-sized population threat
May 18, 2026
The Financial Times took a deep dive into why populations around the world continue to be on the decline. The publication cited new University of Cincinnati research as part of the investigation that looks at the fall of fertility in the digital era.
UC finds integrating substance use disorder treatment into clinic-based internal medicine expands access to care
May 18, 2026
A University of Cincinnati primary care teaching clinic integrates substance use disorder treatment into resident training, expanding access to addiction care and boosting physician confidence.
Colorado silica dust trial could change the way industry does business
May 17, 2026
Betsy Malloy, Andrew Katsanis Professor of Law, at the University of Cincinnati, spoke with Bloomberg Law about how a Colorado trial could change the way the stone fabrication industry does business.